Health

Co-Diagnostics outlines clinical trial timeline and targets mid-2026 commercialization for PCR platform

Earnings Call Insights: Co-Diagnostics, Inc. (CODX) Q2 2025 Management View CEO Dwight H. Egan reported continued progress on the Co-DX PCR point-of-care platform, stating, “We remain on track to initiate clinical evaluations for all tests in our pipeline during 2025.” Egan highlighted imminent clinical evaluations for the COVID-19 test and noted additional pipeline tests including […]
  • maskobus
  • Aug 16, 2025
Health

Pregnancy Infections: No Link to Lower Child IQ, Major Study Shows

Common Maternal Infections During Pregnancy: New Research Offers Reassurance Extensive research, drawing upon nationwide data from Denmark, suggests that routine infections experienced by expectant mothers are unlikely to significantly impact their children’s cognitive abilities later in life. This comprehensive study, one of the largest of its kind, analysed the academic performance and intelligence quotient (IQ) […]
  • maskobus
  • Aug 15, 2025